Skip to main content
OpenTrials
Completed

NCT Number: NCT03939390

Follicular Phase Stimulation vs. Luteal Phase Stimulation in Patients Diagnosed With Suboptimal Response

This study aims to investigate the difference in the number of oocytes obtained by performing ovarian stimulation in follicular phase vs. luteal phase in a population of patients with previous suboptimal response.

This is a controlled randomized clinical study.

We aim to include 41 patients diagnosed with suboptimal response who will undergo an ovarian stimulation in order to vitrify and accumulate oocytes.

The main variable for evaluating the efficacy in this exploratory study will be the number of oocyte cumulus complexes obtained.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–41 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Instituto Bernabeu

Alicante, 03016, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Meets Bologna criteria to be diagnosed as poor responder
  • Less than 10 oocytes obtained in a prior controlled protocol of conventional ovarian stimulation
  • Age < 41 years
  • Body Mass Index (BMI) between 18 and 32 kg/m2
  • Regular menstrual cycles between 21 and 35 days.
  • Indication for in vitro fertilization
  • Indication to start stimulation with 150mcg of corifollitropin alpha
  • Presence of both ovaries
  • Ability to participate and comply with study protocol
  • Signing an informed consent form

Exclusion criteria

  • Presence of follicles larger than 10 mm in the randomization visit
  • Endometriosis stage III/IV
  • Patients with less than 4 oocytes in previous ovarian stimulation and poor ovarian reserve parameters (as per Bologna criteria)
  • Concurrent participation in another study

Treatment and study plan

time of administration of Corifollitropin Alfa

Drug

The treatment will be identical in both arms. The difference between the arms is the moment of the Administration of Corifollitropin Alfa: follicular phase of the menstrual cycle (control group) vs. luteal phase of the menstrual cycle (study group).

Primary outcomes

  1. number of oocytes

    Time frame: at the end of stimulation

    number of oocytes after ovarian stimulation

Sponsors and collaborators

Lead sponsor

Instituto Bernabeu

Other

Registry information

Official study title

Conventional Stimulation in Follicular Phase vs. Luteal Phase Stimulation in Patients With Suboptimal Response. Randomized Clinical Trial. SUBLUTEAL Study

Acronym: SUBLUTEAL

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
May 6, 2019
Registry last updated
Apr 6, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.